Microglia activation is observed in various neurodegenerative diseases. Recent advances in
single-cell technologies have revealed that these reactive microglia were with high spatial …

The clinical features of dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD) are similar and include dementia, cognitive fluctuations, and (visual) hallucinations in …

Neurodegenerative diseases have shown an increasing incidence in the older population in
recent years. A significant amount of research has been conducted to characterize these …

Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …

Aging is the greatest risk factor for most diseases including cancer, cardiovascular disorders,
and neurodegenerative disease. There is emerging evidence that interventions that improve …

Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its
Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT …

The study of the incidence and prevalence of dementia is important to understand the
distribution of dementing illness among age and sex groups, and for the detection of …

With an increasingly aging population, health care providers will treat a higher number of
patients with cognitive impairment. Identifying cognitive impairment and intervening early …

The α-synucleinopathies are a group of neurodegenerative diseases characterized by
abnormal accumulation of insoluble α-synuclein in neurons and glial cells, comprising …

Neurological diseases refer to the diseases that target the nervous system (brain, spine or
nerves). They are the second leading cause of death, and the first cause of severe long-term …